- Anti-SARS-CoV-2 receptor binding domain antibodies after the second dose of Sinovac and AstraZeneca vaccination
-
Gondokesumo ME, Purnamayanti A, Hanum PS, Santosa WN, Wardhana AP, Avanti C
- KMID: 2545219
- Clin Exp Vaccine Res.
- 2023 Jul;12(3):224-231.
- doi: 10.7774/cevr.2023.12.3.224
Purpose: The Sinovac and AstraZeneca vaccines are the primary coronavirus disease 2019 vaccines in Indonesia. Antibody levels in vaccine-injected individuals will decline substantially over time, but data supporting the duration... -
- CITED
-
- Close
- SHARE
-
- Close
